Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evogliptin bone metabolism study
NCT02587975Phase 4Unknown
- Sponsor
- Dongguk University
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of DA5221-B2 in type 2 diabetes mellitus (T2DM), sponsored by Dongguk University. Status: unknown.
02
Drugs
DA5221-B2
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02587975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587975.